Another study has found that an antimalarial drug promoted by President Trump
Donald John Trump Pelosi says Trump’s decision to reverse the fair housing rule is a “betrayal of our nation’s founding values.” Trump says he would consider pardons for those involved in the Mueller investigation. Fauci says he and his family have experienced “serious threats” during the pandemic. MORE and its main advisers are not effective in the treatment of COVID-19 and may cause adverse effects.
The study, published Thursday in the New England Journal of Medicine, found that hydroxychloroquine did not improve outcomes for the 667 COVID-19 patients who participated in a randomized trial in 55 Brazilian hospitals.
In the study, patients with mild to moderate COVID-19 disease were divided into three groups, in which one group received hydroxychloroquine, another group received the drug along with azithromycin, an antibiotic, and the last group received none.
All groups received standard care for COVID-19.
The study found that a seven-day cycle of hydroxychloroquine, with or without the antibiotic, did not give better results.
The study is the latest to show that hydroxychloroquine is ineffective in treating COVID-19, despite the initial hype among doctors, scientists, and politicians that led to the global shortage of the drug.
Some studies have found that the drug can cause adverse effects in patients with COVID-19. In the study published Thursday, patients who took hydroxychloroquine with or without the antibiotic were more likely to experience adverse events, including heart rhythm irregularities, than patients who received the drug alone.
Patients who did not receive any of the medications were less likely to experience adverse effects.
The Food and Drug Administration (FDA) has revoked an emergency use authorization that allowed doctors to treat patients with COVID-19 with hydroxychloroquine outside of clinical trials.
However, the White House began pressuring the FDA to reverse the course after a widely criticized study at Detroit’s Henry Ford Health System found that death rates were lower for patients treated with hydroxychloroquine.
Scientists have criticized the study for being less rigorous than three other studies that showed that hydroxychloroquine is not effective in treating COVID-19 because the drug was not randomly prescribed to patients.
.
